tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AXSM Stock Latest News

Axsome Therapeutics: Strong Growth Trajectory and Financial Outlook Justify Buy Rating
RatingsAxsome Therapeutics: Strong Growth Trajectory and Financial Outlook Justify Buy Rating
9d ago
AXSM
RBC lists biotech winners should RFK depart HHS
PremiumThe Fly
RBC lists biotech winners should RFK depart HHS
18d ago
ALKS
AXSM
RBC lists biotech winners should RFK departure HHS
PremiumThe Fly
RBC lists biotech winners should RFK departure HHS
18d ago
ALKS
AXSM
Axsome Therapeutics assumed with an Overweight at Wells Fargo
PremiumThe Fly
Axsome Therapeutics assumed with an Overweight at Wells Fargo
26d ago
AXSM
Positive Outlook for Axsome Therapeutics Amidst SYMBRAVO’s Market Expansion and Patent Strength
PremiumRatings
Positive Outlook for Axsome Therapeutics Amidst SYMBRAVO’s Market Expansion and Patent Strength
1M ago
AXSM
Axsome Therapeutics Receives Paragraph IV Certification Notice
PremiumCompany AnnouncementsAxsome Therapeutics Receives Paragraph IV Certification Notice
1M ago
8K
AXSM
Axsome Therapeutics management to meet with Needham
Premium
The Fly
Axsome Therapeutics management to meet with Needham
2M ago
AXSM
Axsome Therapeutics: Strong Sales Performance and Promising Growth Trajectory Reinforce Buy Recommendation
Premium
Ratings
Axsome Therapeutics: Strong Sales Performance and Promising Growth Trajectory Reinforce Buy Recommendation
2M ago
AXSM
Axsome Therapeutics: Strong Growth Prospects and Strategic Investments Justify Buy Rating
PremiumRatings
Axsome Therapeutics: Strong Growth Prospects and Strategic Investments Justify Buy Rating
2M ago
AXSM
Axsome Therapeutics’ Earnings Call Highlights Robust Growth
PremiumCompany Announcements
Axsome Therapeutics’ Earnings Call Highlights Robust Growth
2M ago
AXSM
Axsome Therapeutics price target raised to $176 from $173 at BofA
PremiumThe Fly
Axsome Therapeutics price target raised to $176 from $173 at BofA
2M ago
AXSM
Axsome Therapeutics Reports Strong Q2 2025 Growth
PremiumCompany Announcements
Axsome Therapeutics Reports Strong Q2 2025 Growth
2M ago
AXSM
Axsome Therapeutics: Strong Sales Performance and Strategic Growth Initiatives Drive Buy Rating
PremiumRatingsAxsome Therapeutics: Strong Sales Performance and Strategic Growth Initiatives Drive Buy Rating
2M ago
AXSM
Optimistic Outlook for Axsome Therapeutics: Strong Financial Performance and Growth Potential Justify Buy Rating
Premium
Ratings
Optimistic Outlook for Axsome Therapeutics: Strong Financial Performance and Growth Potential Justify Buy Rating
2M ago
AXSM
Strong Growth Prospects and Strategic Advancements Propel Axsome Therapeutics to ‘Buy’ Rating
Premium
Ratings
Strong Growth Prospects and Strategic Advancements Propel Axsome Therapeutics to ‘Buy’ Rating
2M ago
AXSM
Morning Movers: Wayfair surges following second quarter results
PremiumThe Fly
Morning Movers: Wayfair surges following second quarter results
2M ago
W
ON
Axsome Therapeutics: Strong Financial Performance and Strategic Advancements Reinforce Buy Rating
PremiumRatings
Axsome Therapeutics: Strong Financial Performance and Strategic Advancements Reinforce Buy Rating
2M ago
AXSM
Axsome Therapeutics Reports Strong Q2 2025 Performance
PremiumCompany Announcements
Axsome Therapeutics Reports Strong Q2 2025 Performance
2M ago
8K
AXSM
Axsome Therapeutics reports Q2 EPS (97c), consensus ($1.09)
PremiumThe Fly
Axsome Therapeutics reports Q2 EPS (97c), consensus ($1.09)
2M ago
AXSM
AXSM Earnings this Week: How Will it Perform?
PremiumPre-EarningsAXSM Earnings this Week: How Will it Perform?
2M ago
AXSM
Optimistic Outlook for Axsome Therapeutics: Promising Pipeline and Potential Sales Growth Drive Buy Rating
Premium
Ratings
Optimistic Outlook for Axsome Therapeutics: Promising Pipeline and Potential Sales Growth Drive Buy Rating
2M ago
AXSM
Axsome Therapeutics: Undervalued Stock with Promising Pipeline and Near-Term Catalysts
Premium
Ratings
Axsome Therapeutics: Undervalued Stock with Promising Pipeline and Near-Term Catalysts
2M ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >